Quest Diagnostics (DGX) FCF Margin (2009 - 2026)

Quest Diagnostics has reported FCF Margin for 18 years, with the latest figure at 15.08% in Q2 2026.

• Quarterly FCF Margin fell 71.0% year-over-year to 15.08% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 11.67% (up 4.0% YoY) and the FY2025 annual result came in at 12.32%, up 311.0% from the prior year.
• FCF Margin grew to 15.08% in Q2 2026 per DGX's latest filing, from 5.66% in the prior quarter.
• Over five years, FCF Margin peaked at 19.89% in Q4 2023 and troughed at 1.42% in Q1 2023.
• A 5-year average of 10.91% and a median of 12.1% in 2024 frame the typical range for FCF Margin.
• The widest YoY moves for FCF Margin: up 1187 bps in 2023, down 1739 bps in 2023.
• Over 5 years, FCF Margin stood at 8.02% in 2022, then jumped by 148 bps to 19.89% in 2023, then sank by 35 bps to 13.01% in 2024, then decreased by 16 bps to 10.94% in 2025, then jumped by 38 bps to 15.08% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 15.08%, 5.66%, and 10.94% for Q2 2026, Q1 2026, and Q4 2025 respectively.